Zoetis Inc (ZTS)

65.19
0.01 0.02
NYSE : Health Care
Prev Close 65.20
Open 65.29
Day Low/High 64.64 / 65.42
52 Wk Low/High 46.86 / 65.83
Volume 1.58M
Avg Volume 2.25M
Exchange NYSE
Shares Outstanding 489.11M
Market Cap 31.89B
EPS 1.70
P/E Ratio 36.84
Div & Yield 0.42 (0.60%)

Latest News

Investors Need to Closely Watch Mario Draghi's Speech at Jackson Hole: Market Recon

Investors Need to Closely Watch Mario Draghi's Speech at Jackson Hole: Market Recon

What are the chances of a Draghi dovish surprise? I wouldn't bet the farm on anything.

Zoetis Announces Second Quarter 2017 Results

Zoetis Announces Second Quarter 2017 Results

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the second quarter of 2017 and increased its full year guidance for revenue and net income.

Zoetis Appoints Dr. Linda Rhodes To Board Of Directors

Zoetis Appoints Dr. Linda Rhodes To Board Of Directors

Zoetis Inc. (NYSE: ZTS) today announced the appointment of Dr.

Zoetis Completes Acquisition Of Nexvet Biopharma

Zoetis Completes Acquisition Of Nexvet Biopharma

Zoetis Inc. (NYSE:ZTS) and Nexvet Biopharma plc (Nasdaq:NVET) today announced that Zoetis has completed the acquisition of Nexvet, a biologic therapeutics company developing a pipeline of monoclonal antibody (mAb)...

Zoetis To Host Webcast And Conference Call On Second Quarter 2017 Financial Results

Zoetis To Host Webcast And Conference Call On Second Quarter 2017 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.

Who's Afraid of the Amazon Empire?: Cramer's 'Mad Money' Recap (Thursday 6/22/17)

Who's Afraid of the Amazon Empire?: Cramer's 'Mad Money' Recap (Thursday 6/22/17)

Jim Cramer doesn't buy the backlash against Amazon. He says Prime is a very powerful tool and an irresistible bargain.

Citigroup, Zoetis, AbbVie, Mattel, Valeant Pharmaceuticals 'Mad Money' Lightning Round

Citigroup, Zoetis, AbbVie, Mattel, Valeant Pharmaceuticals 'Mad Money' Lightning Round

Jim Cramer is bullish on Citigroup, Zoetis, Idexx Labs, AbbVie, Nucor, and Alexion.

Zoetis To Participate In The William Blair Growth Stock Conference

Zoetis Inc. (NYSE:ZTS) will participate in the William Blair Growth Stock Conference on Tuesday, June 13, 2017, in Chicago, Ill.

Zoetis To Participate In The Stifel 2017 Dental And Veterinary Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2017 Dental and Veterinary Conference on Wednesday, May 31, 2017, in New York, N.

Zoetis: Cramer's Top Takeaways

Zoetis: Cramer's Top Takeaways

Juan Ramon Alaix, CEO of Zoetis, tells Jim Cramer about opportunities in the market for companion animal and livestock vaccines.

Industrials Are Stalling, Techs Are Roaring: Cramer's 'Mad Money' Recap (Monday 5/15/17)

Industrials Are Stalling, Techs Are Roaring: Cramer's 'Mad Money' Recap (Monday 5/15/17)

Jim Cramer says investors are migrating toward sectors likely to have the biggest upside in the second half.

Zoetis Declares Third Quarter 2017 Dividend

The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a third quarter 2017 dividend payable to holders of the company's common stock of $0.

Zoetis Holds Annual Meeting Of Shareholders

Speaking to shareholders at the Zoetis Inc. (NYSE:ZTS) annual meeting today in Short Hills, N.

Forbes Names Zoetis One Of America's Best Employers For Second Year In A Row

Zoetis Inc. (NYSE:ZTS), the global leader in animal health, today announced that it has been named one of America's Best Midsize Employers by Forbes Magazine for the second year in a row.

Photo: Bill & Melinda Gates Foundation/Mulugeta Ayene

Zoetis Inc. (NYSE:ZTS), the largest global animal health company, announced it will receive a US$14.

Oil Slide Puts Market Into Rotation: Cramer's 'Mad Money' Recap (Thursday 5/4/17)

Oil Slide Puts Market Into Rotation: Cramer's 'Mad Money' Recap (Thursday 5/4/17)

Gyrations hit market, as traders drop oil, buy safety.

Cramer: As Fed Moves to Tighten, Other Things Come Unraveled

Cramer: As Fed Moves to Tighten, Other Things Come Unraveled

The list begins with oil, but there's a ripple effect.

Market Recon: The Reflation Trade Still Lives, but Buckle Your Chinstrap

Market Recon: The Reflation Trade Still Lives, but Buckle Your Chinstrap

The Fed's intent is still as plain to see as it was late last year. This committee remains on mission.

Zoetis Announces First Quarter 2017 Results

Zoetis Inc. (NYSE:ZTS) today reported its financial results for the first quarter of 2017 and reaffirmed its guidance for full year 2017.

Zoetis To Participate In The Bank Of America Merrill Lynch Health Care Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Health Care Conference on Wednesday, May 17, 2017, in Las Vegas, Nev.

Zoetis Has Received European Commission Marketing Authorization For Cytopoint (lokivetmab), The First Monoclonal Antibody (mAb) Therapy Approved In The European Union For Veterinary Use. Photo: Zoetis

Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the company marketing authorization for Cytopoint (lokivetmab), the first monoclonal antibody (mAb) therapy approved in the European...

Zoetis To Acquire Nexvet Biopharma, An Innovator In Monoclonal Antibody Therapies For Companion Animals

Zoetis Inc. (NYSE:ZTS) and Nexvet Biopharma plc (Nasdaq:NVET) today announced an agreement in which Zoetis, through a wholly owned subsidiary ("Zoetis Bidco"), will purchase Nexvet, an innovator in monoclonal...

Nick Lachey's Dog, Wookie. Photo: Zoetis.

Zoetis Inc. (NYSE:ZTS), the leading global animal health company, today announced that music and television star Nick Lachey* is teaming up with the company to launch Your Animal Instinct , a program to help your...

Zoetis To Host Webcast And Conference Call On First Quarter 2017 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.

Halliburton, Schlumberger, Alcoa, Celgene:'Mad Money' Lightning Round (3/29/17)

Halliburton, Schlumberger, Alcoa, Celgene:'Mad Money' Lightning Round (3/29/17)

Jim Cramer is bullish on Halliburton, Schlumberger, Cypress Semiconductor and Celgene

This Market Loves Tech: Cramer's 'Mad Money' Recap (Wednesday 3/29/17)

This Market Loves Tech: Cramer's 'Mad Money' Recap (Wednesday 3/29/17)

Tech's organic growth and visibility has been apparent all year, says Jim Cramer.

Impax Gains 38% On CEO Appointment, Talk of Sale

Impax Gains 38% On CEO Appointment, Talk of Sale

The company hired Paul Bisaro, former chairman at Allergan, to become CEO as Morgan Stanley helps explore alternatives, including a sale.

Zoetis Moves Up In Analyst Rankings, Passing Alphabet

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Zoetis Inc has taken over the #25 spot from Alphabet Inc , according to ETF Channel. Below is a chart of Zoetis Inc versus Alphabet Inc plotting their respective rank within the S&P 500 over time (ZTS plotted in blue; GOOGL plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

TheStreet Quant Rating: B+ (Buy)